Tag: CIMac PrimaS

Pathbreaking method leads to optimised mRNA production

Written by
Dr Sekirnik and his team at Sartorius BIA Separations optimised a crucial step in the mRNA production process, resulting in higher yield at lower cost.

The COVID-19 pandemic placed mRNA at the centre of biopharmaceutical research, as mRNA is now being developed for cancer therapy, protein replacement therapy, and infectious diseases. That is why, worldwide, the need to produce mRNA on a large scale has increased dramatically. The currently used method is quite costly, limiting the scale-up of mRNA production. Dr Rok Sekirnik and colleagues […]

Read More… from Pathbreaking method leads to optimised mRNA production